✦ LIBER ✦

Central nervous system metastases in women with HER-2 positive metastatic breast cancer after treatment with trastuzumab

✍ Scribed by Sarah-Jane DAWSON; Nadia F RANIERI; Raymond D SNYDER; Sue-Anne McLACHLAN; William I BURNS; Genni M NEWNHAM; Prudence A FRANCIS; Anthony J DOWLING

Book ID: 111318582
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 72 KB
Volume: 2
Category: Article
ISSN: 1743-7555
DOI: 10.1111/j.1743-7563.2006.00036.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Central nervous system metastases in a c

Central nervous system metastases in a cohort of metastatic breast cancer patients treated with trastuzumab

✍ E. Montagna; G. Cancello; D. D’Agostino; R. Lauria; V. Forestieri; A. Esposito; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 234 KB

Extended survival in women receiving tra

Extended survival in women receiving trastuzumab for brain metastases from HER2 positive metastatic breast cancer

✍ D.N. Church; Modgil; S. Guglani; A. Bahl; K. Hopkins; J.P. Braybrooke; C.G.A. Pr 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Central nervous system progression among

Central nervous system progression among patients with metastatic breast cancer responding to trastuzumab treatment

✍ E. Shmueli; N. Wigler; M. Inbar 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Brain metastases in HER2-positive metast

Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab

✍ Kaplan, Muhammet Ali; Ertugrul, Hamza; Firat, Ugur; Kucukoner, Mehmet; İnal, Ali 📂 Article 📅 2014 🏛 Springer Japan 🌐 English ⚖ 204 KB

Incidence of central nervous system meta

Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA

✍ Swain, S. M.; Baselga, J.; Miles, D.; Im, Y.- H.; Quah, C.; Lee, L. F.; Cortes, 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 145 KB

UK Expanded Access Programme (EAP): Herc

UK Expanded Access Programme (EAP): Herceptin® (trastuzumab) treatment for women with HER2 positive Metastatic Breast Cancer (MBC)

✍ D. Miles; A. Wroath 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 161 KB